1.55 Roundtable Discussion: Evaluating Formulation Feasibility and Optimization Strategies for mRNA-LNP Therapies: Key Considerations for Clinical Advancement
Time: 1:55 pm
day: Day 2- IND-Enabling & Clinical Scale Track PM
Details:
Download the Full Event Guide for session details